Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
Captozyme
3197
Captozyme
Technology
Biotechnology
Captozyme is a preclinical stage biotechnology company dedicated to the enhancement of foods to reduce intake of oxalate.
Suggest edits
Founded
2009
Raised
$3.4M
Follow us
Companies in the same industry
ReAlta Life Sciences
Kriya Therapeutics
Q32Bio
BioFlyte
Cryosa
BioAtla, LLC
IgGenix, Inc
Adlai Nortye
Neogene Therapeutics
Carmot Therapeutics, Inc.
Alexa global traffic share
Overview
Funding
1
Add info
Latest funding
$3,400,000
Venture capital (Series A) - 2017
Team Size
10+
Employees
I work here
Location
United States
Headquarters
Explore United States
$3,400,000
Venture capital (Series A)
prnewswire
Captozyme Secures $3.4 Million to Continue Enzyme Research
